The two lipid-lowering drugs Atorvastatin & Fenofibrate Tablets are used to treat high cholesterol (LDL), high triglycerides, and low “good’ cholesterol (HDL). It helps to reduce heart disease risk, especially for mixed dyslipidemia (a condition characterized by abnormal levels of lipids (cholesterol and triglycerides) in the blood. The tablet formulation contains atorvastatin, which helps to reduce cholesterol production in the liver, while fenofibrate lowers the level of triglycerides in the blood and bad cholesterol. A combination of these active ingredients helps to treat high cholesterol levels.
Composition: Atorvastatin 10mg & Fenofibrate 160mg Tablets
Many patients have experienced some mild to moderate side effects, which are temporary and stable or normal after adjusting to their bodies
A: It combines with cholesterol and triglycerides to protect the same; this fact makes the medication effective in mixed dyslipidemia when one type of drug does not moderate the level of lipid imbalance.
A: It decreases the LDL, triglycerides, and plaque deposits in the arteries, making the blood flow to the heart more efficient and easing the burden on the cardiovascular system in the long run.
A: Yes, cholesterol production decreases with the use of Atorvastatin, and triglyceride concentration decreases with the use of Fenofibrate, providing complete lipid control in the patients who have a combination of lipid disorders.
A: Fenofibrate stimulates lipoprotein lipase, which takes part in the breakdown of lipids in the blood and the overall efficiency in the metabolism of lipids.
A: Yes, it aids in the inhibition of plaque formation in the arteries, slowing more vessel blockage, and facilitating long-term cardiovascular protection.
A: The two drugs are liver and kidney-metabolized drugs, hence any existing conditions might necessitate dose changes or close monitoring.
A: Some patients might complain of muscle or joint pains, and the experienced ones must be reported to avoid complications associated with the muscles that are not common but severe.
A: Jamkas Pharma ensures a high quality of standards and controlled production processes in the manufacturing of cardiovascular therapies that are reliable, safe, and effective.
| Pack Size | 10*10 |
|---|---|
| Pack Type | ALU-2 OR BLISTER |
Office Address: PLOT NO. 295, 1st Floor, Industrial Area Phase 2, Panchkula, Haryana 134113
Factory Address : UNIT-I , Swastik Life Sciences Plot No. 295, 1st Floor, Industrial Area Phase 2, Panchkula, Haryana 134113
Factory Address : UNIT-II , Jamkas Pharmaceuticals Private Limited - Ghatti, Phase 1, SIDCO Industrial Complex, Kalna, Kathua (J&K) -184143
Email: sales1@jamkaspharma.com
Call Us: +91-9541913472
Opening Hours: Mon – Sat (9:00 AM – 6:00 PM)